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ABSTRACT
Background and the purpose of the study: Thymoquinone (TQ) is one of the active components 
of Nigella sativa. The plant has been used in herbal medicine for treatment of many diseases 
including liver complications. The present study aimed to investigate protective effects of TQ 
on Aflatoxin B1 (AFB1) induced liver toxicity in mice. 
Methods: Animals were divided into six groups and treated intraperitoneally. Group 1 (blank) 
served as vehicle, group 2 (positive control) received AFB1, Group 3 was treated with 9 mg/kg 
of TQ, Groups 4, 5 and 6 were treated with 4.5, 9 and 18 mg/kg of TQ, respectively. After three 
consecutive days, except for groups 1 and 3, animals were administered with a single dose of 
AFB1 (2 mg/kg). All the animals were killed 24 hrs following the AFB1 administration under 
ether anesthesia. Biochemical parameters including AST, ALT and ALP in serum samples and 
glutathione (GSH) and malondialdehyde (MDA) contents in liver homogenates were determined. 
Liver sections were collected for histopathological examination. 
Results: Findings of this study showed that AST, ALT, ALP and MDA levels were significantly 
lower in the TQ treated animals as compared to AFB1 group (group 2). Furthermore, TQ was able 
to recover glutathione content (GSH) of liver tissue. The best response, however, was observed 
with the dose of 9 mg/kg. Liver sections of AFB1 intoxicated mice showed inflammation, 
necrosis, hyperplasia of kupffer and infiltration of mononuclear cells, dilation of sinusoids and 
disruption of hepatocytes, while treatment with TQ helped to normalize liver architecture in 
accordance to biochemical findings. 
Conclusion: Taken collectively, TQ has a protective role with optimum dose of 9 mg/kg in 
AFB1 hepatotoxicity.
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INTRODUCTION
The  World  health  organization  (WHO)  estimates 
that  80%  of  the  population  in  some  Asian  and 
African countries are mostly dependent to traditional 
medicine for their health cares (1). In other words, 
about 4 billion people in the world rely on plants as 
source of drugs (2). Among these herbal medicines, 
Nigella sativa is an encouraging medical plant 
reported to have potent antioxidant effects, and 
has  been  used  widely  throughout  the  world.  The 
biological activity of N. sativa is related to it volatile 
oil compounds.  Thymoquinone,  2-isopropyl-5-
methyl-1,  4-benzoquinone,  is  the  major  active 
component of N. sativa and constitutes about 30% 
of its seed extract (3). It has been demonstrated that 
the N. sativa and its chemical components produce 
a variety of pharmacological actions such as anti-
inflammatory, anticancer and antioxidant properties 
and many of these effects are due to TQ (4, 5). The 
beneficial medical effects of N. sativa and TQ have 
been related to their radical scavengering activities 
(6). 
AFB1 is a potent hepatotoxic and hepatocarcinogenic 
compound produced by the fungus, Aspergillus 
flavus (7). The toxicity and carcinogenicity of AFB1 
is thought to be directly linked to its bio-activation, 
resulting in a highly reactive AFB1  8,  9-epoxide 
(8),  which  is  responsible  for  binding  to  cellular 
macromolecules  such  as  RNA,  DNA  and  other 
protein constituents. AFB1 mediated cell damage may 
be due to in vitro and in vivo free radicals release (9) 
and these radicals initiate lipid peroxidation process 
282and antioxidant depletion.
Since oxidative stress processes play an important 
role in AFB1-induced hepatotoxicity and TQ possess 
strong anti-oxidative as well as anti-inflammatory, 
it was reasonable to hypothesize that the TQ could 
be protective against AFB1-induced hepatotoxicity. 
Accordingly, this study was undertaken to investigate 
whether  TQ  protects  against AFB1-induced  acute 
hepatotoxicity in mice and if so, whether the 
protection is dose-dependent. 
MATERIAL AND METHODS
Chemicals
Trichloroacetic  acid  (TCA),  2-thiobarbituric  acid 
(TBA),  n-butanol  were  purchased  from  Merck 
Chemical Company (Darmstadt, Germany). AFB1 
and TQ were provided from Sigma-Aldrich Chemical 
Company (St. Louis, MO, USA). 
Animals
Male  albino  mice  (22-27  g)  were  obtained  from 
animal  house  of  Faculty  of  Pharmacy,  Tehran 
University of Medical Science and quarantined for 
one week prior to use. The animals were kept under 
controlled environmental conditions of temperature 
(25°C),  relative  humidity  of  50-55%,  and  12  hrs 
light/dark cycle. Mice had free access to stock 
laboratory diet (Champus dam) and water. 
Experimental protocol and groups
Following 1 week of acclimatization, the animals 
were randomly divided into six groups, six in each. 
The animals were treated for three consecutive days 
by intraperitoneal (i.p) injection as follows: Group 
1 (Control group) received normal saline solution. 
Group 2 (positive control) received 2mg/kg of AFB1. 
Group 3 received 9 mg/kg of TQ, and groups 4, 5 and 
6 were administrated AFB1 following pretreatment 
with 4.5, 9 and 18 mg/kg of TQ, respectively. After 
the treatment period was over, except for groups 1 
and 3, animals were treated with a single dose of 
AFB1 (2 mg/kg). All the animals were killed 24 hrs 
following AFB1 treatment under ether anesthesia. 
Determination of ALT, ALP and AST activities
Blood samples were obtained by cardiac puncture, 
and serum collected for biochemical assays. 
Activities ALT, ALP and AST were spectrometrically 
determined using kinetic method employing Ellitech 
diagnostic kits (Sees, France) according to the 
manufacturer protocols.
Liver samples
Liver  samples  were  also  removed  by  transverse 
abdominal  incision  and  perfused  with  cold  0.9% 
NaCl, homogenized with three volumes of a solution 
containing 140mM potassium phosphate buffer (pH 
7.0) and centrifuged at 900 g for 15 min at 4°C. The 
supernatant was used as homogenate to assay MDA 
and GSH concentration. Before the homogenate 
process,  a  portion  of  the  liver  was  fixed  in  10% 
formalin for histopathological studies (10). 
Measurement of lipid peroxidation
Lipid peroxidation on liver samples was determined 
by the reaction of TBA with MDA, the end product 
of lipid peroxidations (11). Briefly, liver  homogenate 
samples were mixed with trichloroacetic acid (20%) 
and the precipitate was dispersed into H2SO4 (0.05 
M). TBA (0.2% in 2 M sodium sulfate) was added 
and heated for 30 min in boiling water bath. Lipid 
peroxidation adducts were extracted by n-butanol 
and  absorbance  was  measured  at  532nm.  Results 
were expressed as nmol MDA/g tissue.
Measurement of GSH
GSH were determined by the standard methods (12). 
Results were expressed as µmol GSH/g tissue.
Statistical analyses
The  data  were  expressed  as  means±S.E.  and 
compared using one way analysis of variance 
(ANOVA). Comparisons among groups were made 
according to Tukey-Kramer’s multiple comparisons 
test. The significance level was tested at p<0.05. 
RESULTS 
Effect of TQ on AST, ALT and ALP serum levels
Administration  of  AFB1  significantly  increased 
serum levels of AST, ALT and ALP (Table 1). TQ 
pretreatment was able to reduce the increased levels 
of these enzymes at the employed doses of 4.5, 9 and 
18 mg/kg. The best response was obtained by the 
dose of 9 mg/kg.
Effect of TQ on MDA production in liver
MDA formation, an indicator of lipid peroxidation, 
was expressed as nmol/g tissue. MDA production was 
increased significantly by administrating of AFB1 in 
comparison to control. However, TQ treatment at 
doses of 4.5, 9 and 18 mg/kg significantly prevented 
MDA production (Table 2). The best response was 
obtained by the dose of 9 mg/kg.
Effect of TQ on GSH content of liver
Table 2 demonstrates the total GSH content of the liver 
homogenates. Administration of AFB1 significantly 
reduced  GSH  content  of  liver.  Pre-treatment  with 
TQ  (4.5,  9  and  18  mg/kg)  was  found  to  restore 
significantly hepatic supply of GSH compared to the 
AFB1 group. The best response was observed at the 
dose of 9 mg/kg. Treatment with only TQ (9 mg/kg) 
enhanced hepatic GSH content slightly (Table 2).
Histopathological changes
Table  3  shows  histopathological  changes  in  mice 
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liver following AFB1 administration and with 
TQ  pretreatment.  By  administration  of  only 
AFB1, some histopathological changes in liver 
including  inflammation,  necrosis,  disruptor  of 
hepatocytes, hyperplasia of kupffer cells, infiltration 
of mononuclear cells and increased diameter of 
hepatocytes  were  observed.  TQ  prevented  the 
histopathological changes of AFB1 and decreased 
the number of inflammatory cells. The best response 
was provided by the dose of 9 mg/kg of TQ. Diameter 
of  hepatocyte  as  a  semi-quantitative  indicator  of 
damage  to  the  hepatocytes  (13)  was  reduced  to 
36% by TQ (9 mg/kg) in comparison to AFB1 group 
(Table 4). 
DISCUSION
AFB1 can induce oxidative stress which may lead 
to liver injury (14). Protective activity of TQ was 
evaluated in this study against liver toxicity induced 
by AFB1 in mice. 
The serum levels of hepatic enzymes primarily reflect 
the degree of liver damage and have been commonly 
used as a diagnostic marker for hepatotoxicity (15, 
16). As shown in Table 1, AFB1 (2 mg/kg) significantly 
elevated ALP, AST and ALT which is in agreement 
with results of other studies (7, 17). This finding is 
related well with histopathological examination in 
which necrosis and degradation, disturbed radiated 
hepatocytes, hyperplasia of kupffer cells, infiltration 
of mononuclear cells, inflammation and increase in 
hepatocytes diameter in liver sections were observed. 
TQ prevented the histopathological changes by AFB1 
and decreased the number of inflammatory cells in a 
good relation to the biochemical findings.
Research  has  shown  that TQ,  an  active  principle 
of  Nigella sativa, has hepatoprotective activity 
against tert-butyl hydroperoxide (TBHP) toxicity by 
preventing depletion of GSH and decreasing liver 
enzymes leakage including ALT and AST leakage 
in isolated rat hepatocytes (18). In this study, the 
best response in reducing serum levels of hepatic 
enzymes including AST, ALT and ALP, was observed 
at the dose of 9 mg/kg. Higher doses of TQ (18 
mg/kg), however, provided lesser hepatoprotection 
which might be due to the dose which is close to the 
chemical toxic dose (estimated LD50 104.7 mg/kg; 
89.7-119.7, 95% confidence interval) for mice (19). 
In a preliminary study, it was found that the dose 
of TQ toxicity is 50-100 mg/kg, while a study with 
similar doses (50-100 mg/kg) in Saudi-Arabia had 
shown hepatoprotection. It may be concluded that 
TQ toxicity or TQ resistance have a role in the event. 
The protection monitored by the lower dose of TQ 
(4.5 mg/kg) was also less significant; therefore, it 
Groups ALT (U/L) AST (U/L) ALP (U/L)
Control 31.2 ± 5.2 93.7 ± 6.2 69.3 ± 6.1
TQ (9 mg/kg) 27.5 ± 5.5 90.2 ± 5.6 63.2 ± 6.0
AFB1 (2 mg/kg) 99.8 ± 11.9# 174.3 ± 11.5# 226.1 ± 15.6#
TQ (4.5 mg/kg) + AFB1 (2 mg/kg) 77.4 ± 5.9* 145.8 ± 7.6* 190.6 ± 9.5*
TQ (9 mg/kg) + AFB1 (2 mg/kg) 51.4 ± 4.8*** 130.3 ± 13.2** 154.3 ± 11.9***
TQ (18 mg/kg) + AFB1 (2 mg/kg) 80.4 ± 5.8* 147.6 ± 11.1* 195.4 ± 12.3*
ALT: Alanine aminotransferase 
AST: Aspartate aminotransferase 
ALP: Alkaline phosphatase
Table 1. Protective effect of thymoquinone (TQ) on serum enzyme levels in mice. Statistical analysis used one-way ANOVA with 
Tukey’s test. Values are expressed as means±SE, n=6 for each group. *Significantly different from AFB1 group (P < 0.05); **Significantly             
different from AFB1 group (P < 0.01); ***Significantly different from AFB1 group (P < 0.001); #Significantly different from control group 
(P < 0.001).
Groups Inflam Nec HKC IMNC DS DH
Control _ _ _ _ _ _
TQ (9 mg/kg) _ _ _ _ _ _
AFB1 (2 mg/kg) +++ +++ +++ +++ +++ +++
TQ (4.5 mg/kg) + AFB1 (2 mg/kg) ++ + ++ ++ + +
TQ (9 mg/kg) + AFB1 (2 mg/kg) + _ + + + _
TQ (18 mg/kg) + AFB1 (2 mg/kg) ++ + ++ ++ ++ ++
Table 2. Histopathological changes of liver in experimental groups. Thymoquinone (TQ) was used in doses of 4.5, 9 and 18 mg/kg. 
Histopathological changes including inflammation (Inflam), necrosis (Nec), hyperplasia of kupffer cells (HKC), infiltration of mononuclear 
cells (IMNC), dilation of sinusoids (DS) and disruption of hepatocytes (DH) were studied in comparison to control. Changes: +Moderate, 
++Severe, +++Very severe.Nili-Ahmadabadi et al / DARU 2011 19 (4) 282-287 285
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1a
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Figure 1 (a & b). Effects of thymoquinone (TQ) on malondialdehyde (MDA) and gluthatione content (GSH) of mice liver. Statistical 
analysis used one-way ANOVA with Tukey’s test. Values are expressed as means±SE, n=6 for each group. *Significantly different from 
AFB1 group (P < 0.05); **Significantly different from AFB1 group (P < 0.01); ***Significantly different from AFB1 group (P < 0.001); 
#Significantly different from control group (P < 0.001).
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Figure 2. Effects of thymoquinone (TQ) on diameter of hepatocyte. Statistical analysis used one-way ANOVA with Tukey’s test. All data 
are presented as mean±SE, n=6 for each group.  *Significantly different from AFB1 group (P < 0.05); **Significantly different from AFB1 
group (P < 0.01).
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seems that optimum protective dose of TQ in mice 
liver toxicity induced by AFB1 is about 9 mg/kg. 
Oxidative stress is one of the main indications 
of tissue damages and has been found to play an 
important role in the toxicity and carcinogenesis of 
many toxicants (20, 21). GSH, a key antioxidant, is 
an important constituent of intracellular protective 
mechanisms against various noxious stimuli, 
including oxidative stress (7). In this study, hepatic 
level of MDA as lipid peroxidation index was 
reduced  by TQ  pre-treatment  while  GSH  content 
was considerably restored for toxicity prevention. 
In this regard, maximum protection of liver cells 
against lipid peroxidation and cellular damage 
was obtained at the dose of 9 mg/kg. These results 
further confirm the antioxidant properties of TQ in 
decreasing hepatic toxicity induced by AFB1 or other 
toxins including tert-butyl hydroperoxide (18).
In conclusion, TQ is effective in protection of mice 
against AFB1-induced  hepatotoxicity  possibly  via 
increased resistance to oxidative stress as well as the 
ability to reduce lipid peroxidation at the optimum 
dose of 9 mg/kg.
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